Johnson & Johnson (JNJ)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Johnson & Johnson (JNJ)
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
Key Insights
Critical company metrics and information
Share Price
$149.31Market Cap
$359.48 BillionTotal Outstanding Shares
2.41 Billion SharesTotal Employees
134,400Dividend
$1.24 Per Share QuarterlyIPO Date
September 25, 1944SIC Description
Pharmaceutical PreparationsHomepage
https://www.jnj.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
September 30, 2023 to September 29, 2024
Metric | Value |
---|---|
Net Cash Flow, Continuing | $218.00 Million |
Net Cash Flow From Financing Activities, Continuing | $-6.45 Billion |
Net Cash Flow From Operating Activities | $25.15 Billion |
Net Cash Flow From Operating Activities, Continuing | $25.15 Billion |
Net Cash Flow From Investing Activities, Continuing | $-18.48 Billion |
Net Cash Flow From Investing Activities | $-18.48 Billion |
Exchange Gains/Losses | $34.00 Million |
Net Cash Flow From Financing Activities | $-6.45 Billion |
Net Cash Flow | $252.00 Million |
Income Statement
September 30, 2023 to September 29, 2024
Metric | Value |
---|---|
Benefits Costs and Expenses | $70.07 Billion |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Basic Earnings Per Share | $6.10 |
Net Income/Loss Attributable To Parent | $14.68 Billion |
Revenues | $87.70 Billion |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Income Tax Expense/Benefit | $2.86 Billion |
Costs And Expenses | $70.07 Billion |
Diluted Earnings Per Share | $6.05 |
Cost Of Revenue | $27.14 Billion |
Income/Loss From Discontinued Operations Net Of Tax | $-83.00 Million |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Operating Income/Loss | $17.63 Billion |
Net Income/Loss Available To Common Stockholders, Basic | $14.68 Billion |
Income/Loss From Discontinued Operations Net Of Tax Gain/Loss On Disposal | $0.00 |
Common Stock Dividends | $4.86 |
Gross Profit | $60.55 Billion |
Diluted Average Shares | $2.39 Billion |
Operating Expenses | $42.93 Billion |
Selling, General, and Administrative Expenses | $22.23 Billion |
Net Income/Loss | $14.68 Billion |
Income/Loss From Continuing Operations Before Tax | $17.63 Billion |
Basic Average Shares | $2.37 Billion |
Income/Loss From Continuing Operations After Tax | $14.77 Billion |
Other Operating Expenses | $20.22 Billion |
Income Tax Expense/Benefit, Deferred | $-4.58 Billion |
Balance Sheet
September 30, 2023 to September 29, 2024
Metric | Value |
---|---|
Intangible Assets | $39.49 Billion |
Liabilities And Equity | $178.29 Billion |
Current Liabilities | $51.76 Billion |
Equity Attributable To Noncontrolling Interest | $0.00 |
Noncurrent Assets | $125.04 Billion |
Accounts Payable | $8.95 Billion |
Wages | $3.62 Billion |
Cash | $20.30 Billion |
Equity | $70.16 Billion |
Current Assets | $53.25 Billion |
Noncurrent Liabilities | $56.37 Billion |
Other Non-current Assets | $65.07 Billion |
Liabilities | $108.13 Billion |
Assets | $178.29 Billion |
Other Current Assets | $20.35 Billion |
Other Current Liabilities | $39.19 Billion |
Inventory | $12.60 Billion |
Fixed Assets | $20.48 Billion |
Equity Attributable To Parent | $70.16 Billion |
Historical Dividends
Current dividend: $1.24 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Oct 15, 2024 | Dec 10, 2024 | Nov 26, 2024 | $1.24 | Quarterly |
Jul 17, 2024 | Sep 10, 2024 | Aug 27, 2024 | $1.24 | Quarterly |
Apr 16, 2024 | Jun 4, 2024 | May 21, 2024 | $1.24 | Quarterly |
Jan 2, 2024 | Mar 5, 2024 | Feb 20, 2024 | $1.19 | Quarterly |
Oct 19, 2023 | Dec 5, 2023 | Nov 21, 2023 | $1.19 | Quarterly |
Jul 20, 2023 | Sep 7, 2023 | Aug 28, 2023 | $1.19 | Quarterly |
Apr 18, 2023 | Jun 6, 2023 | May 23, 2023 | $1.19 | Quarterly |
Jan 3, 2023 | Mar 7, 2023 | Feb 21, 2023 | $1.13 | Quarterly |
Oct 19, 2022 | Dec 6, 2022 | Nov 22, 2022 | $1.13 | Quarterly |
Jul 18, 2022 | Sep 6, 2022 | Aug 23, 2022 | $1.13 | Quarterly |
Apr 19, 2022 | Jun 7, 2022 | May 24, 2022 | $1.13 | Quarterly |
Jan 4, 2022 | Mar 8, 2022 | Feb 22, 2022 | $1.06 | Quarterly |
Oct 21, 2021 | Dec 7, 2021 | Nov 23, 2021 | $1.06 | Quarterly |
Jul 19, 2021 | Sep 7, 2021 | Aug 24, 2021 | $1.06 | Quarterly |
Apr 20, 2021 | Jun 8, 2021 | May 25, 2021 | $1.06 | Quarterly |
Jan 4, 2021 | Mar 9, 2021 | Feb 23, 2021 | $1.01 | Quarterly |
Oct 22, 2020 | Dec 8, 2020 | Nov 24, 2020 | $1.01 | Quarterly |
Jul 20, 2020 | Sep 8, 2020 | Aug 25, 2020 | $1.01 | Quarterly |
Apr 14, 2020 | Jun 9, 2020 | May 26, 2020 | $1.01 | Quarterly |
Jan 2, 2020 | Mar 10, 2020 | Feb 25, 2020 | $0.95 | Quarterly |
Oct 17, 2019 | Dec 10, 2019 | Nov 26, 2019 | $0.95 | Quarterly |
Jul 15, 2019 | Sep 10, 2019 | Aug 27, 2019 | $0.95 | Quarterly |
Apr 25, 2019 | Jun 11, 2019 | May 28, 2019 | $0.95 | Quarterly |
Jan 2, 2019 | Mar 12, 2019 | Feb 26, 2019 | $0.9 | Quarterly |
Oct 18, 2018 | Dec 11, 2018 | Nov 27, 2018 | $0.9 | Quarterly |
Jul 16, 2018 | Sep 11, 2018 | Aug 28, 2018 | $0.9 | Quarterly |
Apr 26, 2018 | Jun 12, 2018 | May 29, 2018 | $0.9 | Quarterly |
Jan 2, 2018 | Mar 13, 2018 | Feb 27, 2018 | $0.84 | Quarterly |
Oct 19, 2017 | Dec 12, 2017 | Nov 28, 2017 | $0.84 | Quarterly |
Jul 17, 2017 | Sep 12, 2017 | Aug 29, 2017 | $0.84 | Quarterly |
Apr 27, 2017 | Jun 13, 2017 | May 30, 2017 | $0.84 | Quarterly |
Jan 3, 2017 | Mar 14, 2017 | Feb 28, 2017 | $0.8 | Quarterly |
Oct 20, 2016 | Dec 6, 2016 | Nov 22, 2016 | $0.8 | Quarterly |
Jul 18, 2016 | Sep 6, 2016 | Aug 23, 2016 | $0.8 | Quarterly |
Apr 28, 2016 | Jun 7, 2016 | May 24, 2016 | $0.8 | Quarterly |
Jan 4, 2016 | Mar 8, 2016 | Feb 23, 2016 | $0.75 | Quarterly |
Oct 22, 2015 | Dec 8, 2015 | Nov 24, 2015 | $0.75 | Quarterly |
Apr 23, 2015 | Jun 9, 2015 | May 26, 2015 | $0.75 | Quarterly |
Jan 5, 2015 | Mar 10, 2015 | Feb 24, 2015 | $0.7 | Quarterly |
Oct 16, 2014 | Dec 9, 2014 | Nov 25, 2014 | $0.7 | Quarterly |
Jul 21, 2014 | Sep 9, 2014 | Aug 26, 2014 | $0.7 | Quarterly |
Apr 24, 2014 | Jun 10, 2014 | May 27, 2014 | $0.7 | Quarterly |
Jan 2, 2014 | Mar 11, 2014 | Feb 25, 2014 | $0.66 | Quarterly |
Oct 17, 2013 | Dec 10, 2013 | Nov 26, 2013 | $0.66 | Quarterly |
Jul 15, 2013 | Sep 10, 2013 | Aug 27, 2013 | $0.66 | Quarterly |
Apr 25, 2013 | Jun 11, 2013 | May 28, 2013 | $0.66 | Quarterly |
Jan 2, 2013 | Mar 12, 2013 | Feb 26, 2013 | $0.61 | Quarterly |
Oct 17, 2012 | Dec 11, 2012 | Nov 27, 2012 | $0.61 | Quarterly |
Related Companies
View additional S&P 500 companies similar to Johnson & Johnson (JNJ)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.